Acetyl hexapeptide-3
Names | |
---|---|
Other names
| |
Identifiers | |
616204-22-9 | |
3D model (Jmol) | Interactive image Interactive image |
ChemSpider | 9403386 |
PubChem | 11228338 |
UNII | L4EL31FWIL |
| |
| |
Properties | |
C34H60N14O12S | |
Molar mass | 889.00 g·mol−1 |
Related compounds | |
Related compounds |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Acetyl hexapeptide-3 or acetyl hexapeptide-8 (sources differ) is a synthetic anti-wrinkle cosmetics ingredient. It is a peptide which is a fragment of SNAP-25, a substrate of Botulinum toxin (Botox). Acetyl hexapeptide-8 is marketed as Argireline by the Barcelona-based research laboratory Lipotec.[1]
Overview and common uses
Argireline is used in attempts to decrease the visible effects of aging by reducing the deep wrinkles and lines that occur around the forehead and eyes.[1][2]
Chemically, when applied as a solution to specific areas of the face, Argireline inhibits the reactions that cause muscles to move or contract[1] – for example when forming facial expressions such as smiling or frowning.
Cosmetic studies
Both in vitro (outside a living organism) and in vivo (using a living organism) tests have been carried out on Argireline, but double-blind clinical trials results have not been published.
Safety research
Argireline has been developed relatively recently and therefore reports on its long-term use have not yet been produced.
Chemistry
Argireline is the hexapeptide with the sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2.[1]
References
- 1 2 3 4 Blanes-Mira, C; et al. (October 2002). "A synthetic hexapeptide (Argireline) with antiwrinkle activity". Int J Cosmet Sci. 24 (5): 303–10. doi:10.1046/j.1467-2494.2002.00153.x. PMID 18498523.
- ↑ Ruiz, MA; Clares, B; Morales, ME; Cazalla, S; Gallardo, V (2007). "Preparation and stability of cosmetic formulations with an anti-aging peptide.". Journal of cosmetic science. 58 (2): 157–71. PMID 17520155.